Groowe Groowe / Newsroom / BEAM
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BEAM News

Beam Therapeutics Inc. Common Stock

Beam Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates

globenewswire.com
BEAM

Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting

globenewswire.com
BEAM